AGEN1423 and Botensilimab w/ or w/o Chemo in PDAC

NCT05632328 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Advanced Pancreatic Ductal Adenocarcinoma
Pancreatic Ductal Adenocarcinoma
Pancreatic Cancer

Interventions

DRUG: AGEN1423
DRUG: Botensilimab
DRUG: Gemcitabine
DRUG: Nab-paclitaxel

Sponsor

Bruno Bockorny

Collaborators

[object Object]
[object Object]